A rare case study: pre-excited atrial fibrillation in Wolff-Parkinson white syndrome associated with partial ventricular septal defect

Authors

  • Viktor Snezhitskiy Department of Internal Medicine, Grodno State Medical University, Belarus, Europe
  • Marina Matsiukevich Department of Internal Medicine, Grodno State Medical University, Belarus, Europe
  • Naveen D. K. N. Direcksze Department of Internal Medicine, Grodno State Medical University, Belarus, Europe https://orcid.org/0009-0005-5714-0105
  • Prithvi A. Dineshkumar Department of Internal Medicine, Grodno State Medical University, Belarus, Europe
  • M. N. M. Afham Department of Internal Medicine, Grodno State Medical University, Belarus, Europe

DOI:

https://doi.org/10.18203/2320-6012.ijrms20251323

Keywords:

Wolff-Parkinson-white syndrome, Ventricular septal defect, Atrial fibrillation

Abstract

Wolff–Parkinson–white (WPW) syndrome is a congenital disorder affecting the hearts’ conduction system, which is recognized by the existence of an accessory pathway (AP) that can lead to pre-excitation of ventricles, paroxysmal supraventricular tachycardias and in severe cases to sudden cardiac death. Thus, AP usually has non-decremental conduction allowing immediate ventricular activation which in case of AF leads to rapid ventricular response with high risk of transformation into ventricular fibrillation and cardiac arrest. Physical examination of this patient revealed the following clinical manifestations of WPW syndrome like severe tachycardia, dizziness and presyncope. The lab findings revealed an increase in the high-sensitive troponin I suggesting the underlying result from atrial fibrillation. And hyperbilirubinemia was shown in the biochemical analysis confirming the concomitant disease of this patient which is Gilbert’s Syndrome. The ECGs depicted the presence of a type A WPW pattern and paroxysmal form of atrial fibrillation (AF). The echocardiograms disclosed the presence of ventricular septal defect (VSD) in the membranous part of the interventricular septum. Both the ECGs and Echocardiograms revealed type A WPW pattern and paroxysmal form of atrial fibrillation respectively. The patient’s heart rate was monitored routinely in the intensive care unit with the help of 24-hour Holter monitoring device, breathing rate and blood pressure to detect the evaluation the patient’s prognosis. This article enhances the difficulties in differential diagnosis, experience of amiodarone uses in acute management, interventional treatment of pre-excited AF and VSD, because this can be a primary manifestation in young patients.

Metrics

Metrics Loading ...

References

Bhattacharyya S, Munshi NV. Development of the cardiac conduction system. Cold Spring Harbor Persp Biol. 2020;12(12):37408. DOI: https://doi.org/10.1101/cshperspect.a037408

Chhabra L, Goyal A, Benham MD. Wolff-Parkinson-White Syndrome. InStatPearls. StatPearls publishing.

Sethi KK, Dhall A, Chadha DS, Garg S, Malani SK, Mathew OP. WPW and preexcitation syndromes. J Asso Phys India. 2007;55:10.

Jemtrén A, Saygi S, Åkerström F, Asaad F, Bourke T, Braunschweig F, et al. Risk assessment in patients with symptomatic and asymptomatic pre-excitation. Europace. 2024;26(2):36. DOI: https://doi.org/10.1093/europace/euae036

Saka A. Determination of factors influencing the activities of pr interval on the electrocardiogram (ecg) in an experiment of the factorial Type. Int J Clin Biostat Biom. 2021;7:041.

Vătășescu RG, Paja CS, Șuș I, Cainap S, Moisa ȘM, Cinteză EE. Wolf–parkinson–white syndrome: diagnosis, risk assessment, and therapy—an update. Diagnos. 2024;14(3):296. DOI: https://doi.org/10.3390/diagnostics14030296

Murphy SD, Torlutter M. The use of vagal manoeuvres in narrow complex tachyarrhythmias in primary care. South African Family Practice. 2022;64(1):56. DOI: https://doi.org/10.4102/safp.v64i1.5413

Green JR, Bartley TD, Schiebler GL. The Wolff-Parkinson-White Syndrome and Ventricular Septal Defect: A Case Report of Successful Surgery in an 18-Year-Old Man. Diseases of the Chest. 1965;47(6):659-62. DOI: https://doi.org/10.1378/chest.47.6.659

Saka A. Determination of Factors Influencing the Activities of PR Interval on the Electrocardiogram (ECG) in an Experiment of the Factorial Type. Int J Clin Biostat Biom. 2021;7:41. DOI: https://doi.org/10.23937/2469-5831/1510041

Wellens HJ, Bär FW, Gorgels AP, Vanagt EJ. Use of ajmaline in patients with the Wolff-Parkinson-White syndrome to disclose short refractory period of the accessory pathway. Am J Cardiol. 1980;45(1):130-3. DOI: https://doi.org/10.1016/0002-9149(80)90230-1

Wellens HJJ, Braat SH, Brugada P, Gorgels AP, Bar FW. Use of procainamide in patients with the Wolff-Parkinson-White syndrome to disclose a short refractory period of the accessory pathway. Am J Cardiol. 1982;50:921–25. DOI: https://doi.org/10.1016/0002-9149(82)90422-2

Khairy P, Van Hare GF. PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease. Can. J. Cardiol. 2014;30:53. DOI: https://doi.org/10.1016/j.cjca.2014.09.002

Brady WJ, Mattu A, Tabas J, Ferguson JD. The differential diagnosis of wide QRS complex tachycardia. Am J Emerg Med. 2017;35(10):1525-9. DOI: https://doi.org/10.1016/j.ajem.2017.07.056

Schatz I, Ordog GJ, Karody R. Wolff-Parkinson-White syndrome presenting in atrial fibrillation. Ann Emerg Med. 1987;16:574-8. DOI: https://doi.org/10.1016/S0196-0644(87)80691-1

Svendsen JH, Dagres N, Dobreanu D, Bongiorni MG, Marinskis G, Blomström-Lundqvist C. Conducted by the Scientific Initiatives Committee, European Heart Rhythm Association. Current strategy for treatment of patients with Wolff–Parkinson–White syndrome and asymptomatic preexcitation in Europe: European Heart Rhythm Association survey. Europace. 2013;15(5):750-3. DOI: https://doi.org/10.1093/europace/eut094

Hamer AW, Mandel WJ, Zaher CA, Karagueuzin HS, Peter T. The electrophysiological basis for the use of amiodarone for treatment of cardiac arrhythmias. Pacing Clin Electrophysiol. 1983;6:784–94. DOI: https://doi.org/10.1111/j.1540-8159.1983.tb05340.x

Crozier I. Flecainide in the Wolff-Parkinson-white syndrome. Am J Cardiol. 1992;70(5):26-32. DOI: https://doi.org/10.1016/0002-9149(92)91074-E

Calkins H, Camm AJ, Campbell WB, Haines DE, Kuck KH, Lerman B. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias-executive summary. European Heart J. 2003;24:1857-97. DOI: https://doi.org/10.1016/j.ehj.2003.08.002

Ludmer PL, McGowan NE, Antman EM, Friedman PL. Efficacy of propafenone in Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up. J Am College of Cardiol. 1987;9(6):1357-63. DOI: https://doi.org/10.1016/S0735-1097(87)80478-3

Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. New England J Med. 2011;365(10):883-91. DOI: https://doi.org/10.1056/NEJMoa1009638

Prystowsky EN, Greer S, Packer DL, Thompson KA, German LD. Beta-blocker therapy for the Wolff-Parkinson-White syndrome. The American J Cardiol. 1987;60(6):46-50. DOI: https://doi.org/10.1016/0002-9149(87)90708-9

Brugada J, Katritsis DG, Arbelo E. supraventricular tachycardia the task force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC) developed in collaboration with the association for European pediatric and congenital Cardiology (AEPC). European Heart J. 2019;41(5):655-720. DOI: https://doi.org/10.1093/eurheartj/ehz467

Downloads

Published

2025-04-29

How to Cite

Snezhitskiy, V., Matsiukevich, M., Direcksze, N. D. K. N., Dineshkumar, P. A., & Afham, M. N. M. (2025). A rare case study: pre-excited atrial fibrillation in Wolff-Parkinson white syndrome associated with partial ventricular septal defect. International Journal of Research in Medical Sciences, 13(5), 2140–2144. https://doi.org/10.18203/2320-6012.ijrms20251323

Issue

Section

Case Reports